Cargando…

Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3)

We investigated whether T cell-recruiting bispecific anti-CD3/GD2 antibody NG-CU might be an alternative to therapeutic anti-GD2 monoclonal antibody (mAb) ch14.18, mediating complement-dependent cytotoxicity (CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC) through natural killer (NK) c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arendt, A.-M., Heubach, F., Maier, C. P., Giardino, S., Jung, G., Kowalewski, E., Rabsteyn, A., Amorelli, G., Seitz, C., Schlegel, P., Handgretinger, R., Lang, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576705/ https://www.ncbi.nlm.nih.gov/pubmed/37742286 http://dx.doi.org/10.1007/s00262-023-03536-x

Ejemplares similares

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment
por: Seitz, Christian Martin, et al.
Publicado: (2021)

Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients
por: Lode, Holger, et al.
Publicado: (2013)

Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells
por: Fisher, Jonathan P H, et al.
Publicado: (2015)

Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD(2) Antibody
por: Siebert, Nikolai, et al.
Publicado: (2014)

Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia
por: Terme, Mickaël, et al.
Publicado: (2014)

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD(2) antibody ch14.18/CHO
por: Mueller, Ina, et al.
Publicado: (2017)

Correction: Chimeric Antibody c.8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia
Publicado: (2014)

Reduction of CD11b(+) myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD(2) antibody ch14.18/CHO
por: Siebert, Nikolai, et al.
Publicado: (2020)

Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells
por: Yankelevich, Maxim, et al.
Publicado: (2023)

GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
por: Park, Jeong A., et al.
Publicado: (2020)

Self-patterning Gd nano-fibers in Mg-Gd alloys
por: Li, Yangxin, et al.
Publicado: (2016)

Digital TDPAC with rare earth isotope $^{169}$Yb, $^{147}$Gd, and $^{149}$Gd in Yb and Gd Doped CeO$_{2}$ and $^{147}$Gd in GdBa$_{2}$ Cu$_{3}$ O$_{7−\delta}$
por: Roeder, Jens, et al.
Publicado: (2011)

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells
por: Tivnan, Amanda, et al.
Publicado: (2017)

Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy
por: Simon, Thorsten, et al.
Publicado: (2011)

The effects of three different contrast agents (Gd-BOPTA, Gd-DTPA, and Gd-DOTA) on brachial plexus magnetic resonance imaging
por: Zhang, Xiaojing, et al.
Publicado: (2021)

GD2 and GD3 synthase: novel drug targets for cancer therapy
por: Sphyris, Nathalie, et al.
Publicado: (2015)

GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells
por: Seitz, Christian M., et al.
Publicado: (2019)

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2
por: Hoseini, Sayed Shahabuddin, et al.
Publicado: (2017)

Measurement of the neutron capture cross section for $^{155}$Gd and $^{157}$Gd for Nuclear Technology
por: Lo Meo, Sergio, et al.
Publicado: (2015)

Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
por: Yanagisawa, Makoto, et al.
Publicado: (2011)

Ganglioside GD3 synthase (GD3S), a novel cancer drug target
por: Liu, Jinyi, et al.
Publicado: (2018)

Gd-DTPA Adsorption on Chitosan/Magnetite Nanocomposites
por: Pylypchuk, Ie. V., et al.
Publicado: (2016)

Giant exchange coupling and field-induced slow relaxation of magnetization in Gd(2)@C(79)N with a single-electron Gd–Gd bond
por: Velkos, G., et al.
Publicado: (2018)

Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles
por: Rääf, C., et al.
Publicado: (2020)

GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2021)

gD-Independent Superinfection Exclusion of Alphaherpesviruses
por: Criddle, A., et al.
Publicado: (2016)

Favoured neutron excitations in superdeformed $^{147}$Gd
por: Theisen, C, et al.
Publicado: (1995)

PSAT345 Neonatal Graves (NG) Affecting 3 Newborns of a Mother Treated with Radioactive Iodine (RAI) for Graves’ Disease (GD)
por: Ali, Dalal S, et al.
Publicado: (2022)

Chirality and Magnetocaloricity in GdFeTeO(6) as Compared to GdGaTeO(6)
por: Zvereva, Elena, et al.
Publicado: (2021)

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
por: Galan, Alba, et al.
Publicado: (2023)

Coupling Gd-DTPA with a bispecific, recombinant protein anti-EGFR-iRGD complex improves tumor targeting in MRI
por: XIN, XIAOYAN, et al.
Publicado: (2016)

Trivalent Gd-DOTA reagents for modification of proteins
por: Fisher, Martin J., et al.
Publicado: (2015)

Implantation sites of Ce and Gd in diamond
por: Bharuth-Ram, K, et al.
Publicado: (2002)

Thermochemical investigations in the system Cd–Gd
por: Reichmann, Thomas L., et al.
Publicado: (2014)

Reinvestigation of the Cd–Gd phase diagram
por: Reichmann, Thomas L., et al.
Publicado: (2014)

GD2 expression in breast cancer
por: Orsi, Giulia, et al.
Publicado: (2017)

Actualización PAPPS GdT Mayor 2020()
por: Gorroñogoitia Iturbe, Ana, et al.
Publicado: (2020)

An Unusual Trigger of Grover’s Disease (GD)
por: Haniff, Shaniza, et al.
Publicado: (2023)

Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins
Publicado: (1986)

High-sensitivity Gd(3+)–Gd(3+) EPR distance measurements that eliminate artefacts seen at short distances
por: EL Mkami, Hassane, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_395uu8uv8hcel37veqg3p4crov